New England Cancer Specialists

Clinical research site in Scarborough, Maine · New England Cancer Specialists - Rock Row, 11 Rock Row, Westbrook, ME 04092 · (207) 303-3300 · Website

Part of New England Cancer Specialists

As of July 2026, 7 paid clinical trials are recruiting at New England Cancer Specialists in Scarborough, Maine. Active studies at this site cover conditions such as Breast Cancer, HER2-positive Breast Cancer and Chronic Lymphocytic Leukemia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at New England Cancer Specialists (7)

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

for HER2-positive Breast Cancer

22 locations incl. Long Beach

Sponsor: Jazz Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07102381·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for Triple Negative Breast Cancer

124 locations incl. Birmingham

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT05633654·Phase 3·Recruiting·Listed Dec 2022

Apply to this trial

A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer

54 locations incl. Daphne

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT06065748·Phase 3·Recruiting·Listed Oct 2023

Apply to this trial

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

for Lymphoma, Non-Hodgkin

146 locations incl. Birmingham

Sponsor: American Society of Clinical Oncology

Sex: All·Age: 12+

Code: NCT02693535·Phase 2·Recruiting·Listed Feb 2016

Apply to this trial

ATEMPT 2.0: Adjuvant T-DM1 vs TH

for Breast Cancer

47 locations incl. San Francisco

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT04893109·Phase 2·Recruiting·Listed May 2021

Apply to this trial

Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia

for Chronic Lymphocytic Leukemia

4 locations incl. Scarborough

Sponsor: Inhye Ahn

Sex: All·Age: 18+

Code: NCT06333262·Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

Zanubrutinib and Venetoclax in CLL (ZANU-VEN)

for Chronic Lymphocytic Leukemia (CLL)

4 locations incl. Scarborough

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT05168930·Phase 2·Recruiting·Listed Dec 2021

Apply to this trial

More research sites in Scarborough

MaineHealth Maine Medical Center- Scarborough (40 trials)
Maine Children's Cancer Program (25 trials)
Maine Medical Center - Scarborough Campus (3 trials)
Clinical Trial Site (1 trial)
Local Institution - 0127 (1 trial)
MMP Neurology (1 trial)
Maine Center For Cancer Medicine (1 trial)
Maine Health Cancer Care (1 trial)
Maine Health Cardiology (1 trial)
Maine Hemophilia and Thrombosis Center (1 trial)

Explore more

Paid clinical trials in Scarborough, ME · Maine clinical trials